McMullan Christel, Hughes Sarah E, Aiyegbusi Olalekan Lee, Calvert Melanie
Institute of Applied Health Research, University of Birmingham, Birmingham, UK.
Centre for Patient Reported Outcomes Research, University of Birmingham, Birmingham, UK.
Heliyon. 2023 May 23;9(6):e16453. doi: 10.1016/j.heliyon.2023.e16453. eCollection 2023 Jun.
People affected by cancer experience a wide range of symptoms which have a major impact on their functioning and health-related quality of life (HRQoL). One way to measure the impact of cancer symptoms is through the use of patient-reported outcomes.
An electronic patient-reported outcome (ePRO) application (ChemoPRO®) was designed to be used by cancer patients to report their symptoms and communicate with their clinical team. Usability testing sessions were conducted with people with lived experience of cancer to understand how real users interact with the ChemoPRO® system. One-to-one testing sessions were conducted to assess use of the system and identify areas for further refinement. User satisfaction was assessed using a brief satisfaction questionnaire previously used by Aiyegbusi et al. (date).
Ten people with lived experience of cancer took part in the usability study. Symptoms and HRQoL measures, including the Euroqol EQ5D5L and the PRO-CTCAE™ were included in the ePRO system.
had a mean age of 62.3 years. Three critical errors and 21 non-critical errors were reported. All participants were enthusiastic about the app. Participants liked the simplicity and responsiveness of the patient-facing app and highlighted the potential for communicating with their clinical team. The overall usability and satisfaction score was 4.5 (sd = 0.09).
This usability study suggests that people with lived experience of cancer found the ChemoPRO® app acceptable and easy to use. One of the key features of this particular ePRO system that should be developed further is system functionality to facilitate communication between patients and clinicians. Future testing should include testing in a clinical setting and testing with people from ethnic minorities.
癌症患者会经历各种各样的症状，这些症状对他们的身体机能和健康相关生活质量（HRQoL）有重大影响。衡量癌症症状影响的一种方法是通过使用患者报告结局。
设计了一种电子患者报告结局（ePRO）应用程序（ChemoPRO®），供癌症患者用来报告他们的症状并与临床团队进行沟通。对有癌症亲身经历的人进行了可用性测试，以了解真实用户如何与ChemoPRO®系统交互。进行了一对一测试，以评估系统的使用情况并确定需要进一步改进的方面。使用Aiyegbusi等人（日期）之前使用的简短满意度问卷评估用户满意度。
十名有癌症亲身经历的人参与了可用性研究。ePRO系统中包括症状和HRQoL测量指标，如欧洲五维度健康量表（Euroqol EQ5D5L）和患者报告的癌症治疗相关不良事件量表（PRO-CTCAE™）。
平均年龄为62.3岁。报告了3个严重错误和21个非严重错误。所有参与者都对该应用程序充满热情。参与者喜欢面向患者的应用程序的简单性和响应性，并强调了与临床团队沟通的潜力。总体可用性和满意度得分为4.5（标准差=0.09）。
这项可用性研究表明，有癌症亲身经历的人认为ChemoPRO®应用程序是可接受且易于使用的。这个特定ePRO系统应进一步开发的关键特性之一是促进患者与临床医生之间沟通的系统功能。未来的测试应包括在临床环境中的测试以及对少数民族人群的测试。
